Clinicians can mitigate anemia during cancer treatment by reducing the dose, switching to alternate-day dosing, or providing growth factor support.

In an interview with Pharmacy Times, Brandon Kasberg, PharmD, discusses how pharmacists can help individualize multimodal acute pain regimens, reduce unnecessary opioid exposure, and support safer transitions from inpatient or postoperative care to the outpatient setting.

This FAQ breaks down which drugs are covered by the program, who qualifies, how to process claims correctly, and what pharmacists need to know to counsel patients through this landmark shift in obesity drug access.

Emerging data on psychedelics demonstrate efficacy in preventing cluster headaches.

VMAT2 inhibitors show lasting benefit and strong tolerability; dosing, drug interactions, swallowing needs, and liver changes guide switching and long-term use.

Learn how pharmacists use simple talks, handouts and motivational interviewing to start TD therapy early—and choose VMAT2 dosing for adherence.